The global Prescription Eyeglass Sold Through Pharmacy & Drug Store Market is experiencing steady growth, driven by increasing prevalence of refractive errors, an aging population, and consumer demand for convenient, accessible vision care solutions. The prescription segment dominates the broader spectacles market, capturing an 87.07% share in 2026 . With approximately 1.68 million people in the United States alone using prescription eyeglasses , pharmacies and drug stores have emerged as vital distribution channels offering accessible vision correction solutions. For comprehensive market analysis, refer to the Prescription Eyeglass Sold Through Pharmacy & Drug Store Market report for detailed forecasts and competitive intelligence.

Market Dynamics

Rising Prevalence of Refractive Errors and Aging Population Drive Core Demand

The increasing global burden of vision impairment is a primary growth driver for prescription eyeglasses sold through pharmacies and drug stores. Prescription eyeglasses remain the largest category in the eyewear market, with global prescription spectacles representing approximately 70% of eyewear demand in FY2025 . In Japan, about 68% of the population was affected by refractive errors in FY2025, with this figure projected to increase to 71% by FY2030, driven by an aging population that increases the incidence of presbyopia and sustained demand for refractive error correction . In Asia Pacific, over 495 million pairs of spectacles were sold in 2025, with prescription spectacles forming the dominant segment because corrective vision needs create recurring, non-discretionary demand across age groups . The prevalence of myopia among teenagers in urban centers in China is the highest worldwide, spurring unprecedented demand for prescription glasses .

Pharmacy and Drug Store Channel Advantages

Pharmacies and drug stores offer unique advantages as prescription eyeglass distribution channels, including convenient locations, extended operating hours, and integrated healthcare services . Retail stores, including pharmacies, are expected to lead the distribution channel segment with a 79.58% share in 2026, driven by the increasing number of retail establishments and growing consumer adoption . Pharmacies and drug stores benefit from their role as trusted healthcare destinations, where consumers can conveniently purchase prescription eyeglasses alongside other health and wellness products. These channels are also increasingly offering comprehensive vision care services, including eye exams and lens fitting, creating one-stop solutions for consumers.

Value-Focused Models and Direct-to-Consumer Integration

The prescription eyeglass market is undergoing a structural shift toward value-focused models, which is influencing pharmacy and drug store channels. In Japan, value-focused direct-to-consumer brands grew at a CAGR of 6-8% from FY2020-2025, with market share rising from 24-26% to 30-32% . These players gained traction by offering functional, fashionable, and quick-service eyewear through fixed-price, all-inclusive packages that disrupted the traditional model of charging separately for frames, lenses, and additional coatings . Pharmacies are increasingly integrating these value-focused offerings, making prescription eyeglasses more accessible to a broader consumer base. The market share of D2C brands is projected to rise to 40-45% by FY2030 .

Organised Retail Expansion and Prescription Eyeglass Integration

Organised retailers, including pharmacy chains, are gaining market share in the prescription eyeglass segment. In Japan, organised retailers have witnessed a slightly higher CAGR of 4-5% from FY2020-2025, compared to a CAGR of 2-3% for the overall prescription eyeglasses market . This growth is driven by private labels and a direct-to-consumer approach . The organised retail share of the overall eyewear market is projected to increase from approximately 63% in FY2025 to 69% by FY2030, as these players continue to gain ground over unorganised retailers and traditional multi-brand optical chains . Pharmacies and drug stores are well-positioned to benefit from this trend through their established retail infrastructure and customer base.

Regional Outlook

North America continues to lead the prescription eyeglass market, with the United States being a significant driver where approximately 168 million people use prescription eyeglasses . The Asia Pacific region is experiencing rapid growth, with market size reaching USD 41,230 million in 2025, projected to grow at a CAGR of 7.37% to USD 44,611 million in 2026 . India presents the strongest large-market growth outlook with a CAGR of 11.4%, while China remains the largest country market at USD 16,780 million . Japan, with a stable market valued at approximately USD 8.0 billion in FY2025, demonstrates growth opportunities driven by its aging population . Europe maintains steady growth with increasing adoption of pharmacy-based vision care solutions.

Competitive Landscape

The competitive landscape features established optical retailers, pharmacy chains, and direct-to-consumer brands. Key players include EssilorLuxottica, Lenskart, Warby Parker, and major pharmacy chains such as CVS Health, Walgreens, and Boots. In Asia Pacific, Lenskart demonstrates the strategic value of omnichannel scale with 2,067 stores in India and 656 internationally . EssilorLuxottica reported a 9.0% constant-currency increase in first-half 2025 Asia Pacific revenue . The competitive environment emphasizes product innovation, value-based pricing, and integrated vision care services. Strategic partnerships between pharmacy chains and eyewear manufacturers are increasingly common.

Conclusion

The prescription eyeglass sold through pharmacy and drug store market is poised for strong growth, driven by rising vision impairment prevalence, aging populations, and the convenience of pharmacy-based distribution. The prescription segment's 87.07% market share  and Asia Pacific's projected growth trajectory signal sustained opportunities. Pharmacy retailers investing in integrated vision care services, value-focused offerings, and strategic brand partnerships will capture disproportionate market share.

Read Our Related Reports

FAQs

1. What is driving growth in the prescription eyeglass sold through pharmacy market?
Growth is driven by increasing prevalence of refractive errors, aging populations, and consumer demand for convenient healthcare access. Prescription eyeglasses represent approximately 70% of eyewear demand globally , with pharmacies emerging as key accessible channels.

2. What distribution channels dominate the prescription eyeglass market?
Retail stores, including pharmacies and drug stores, are expected to lead with a 79.58% share in 2026 . Online stores are experiencing the highest CAGR due to benefits like wider product selection and discounts .

3. Which regions show the strongest growth potential?
Asia Pacific demonstrates strong growth, with China as the largest market at USD 16,780 million . India offers the strongest large-market growth outlook at 11.4% CAGR .